NCT00038675: Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
- State
- Completed
- Phase
- No phase
- People
- 125 taking part
- Started
- Jun 2001
- Primary completion
- Nov 2013
- Arms
- Imatinib
- Results
- Posted on the registry
- 5 Jun 2002: Trial registered
- 4 Jan 2022: Trial results posted